Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Wales’ New Treatments Fund

- PMLiVE

NICE in U-turn on Novartis’ Lucentis in diabetic macular oedema

Patient access scheme influences draft recommendation

- PMLiVE

UK government launches Healthwatch England to champion patient voices

Will support public opinion in health and social care

A new dogma in HTA assessment

New communication routes to HTA agencies are needed to ensure that these organisations can advise on clinical trial design

- PMLiVE

The bigger picture in medicine value

By focusing on cost are we obscuring the true value of medicines?

- PMLiVE

UK NHS reforms create £20bn opportunity for private sector

Report from Catalyst says NHS reforms pave way for healthcare companies

- PMLiVE

Postcards from China

Part two: The value of innovative medical education in China

- PMLiVE

How should industry support rising stars in the East?

Nick Willhoft of Noveida discusses ways of engaging with Asia's young, influential healthcare thought leaders

- PMLiVE

Demonstrating value and improving access

In today’s dynamic healthcare market, it’s all about how we can demonstrate value and improve access – it is the art of effective communication and education that will enable success

- PMLiVE

UK hospitals cannot cope with demand says RCP

Report claims acute care on “brink of collapse”

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

- PMLiVE

Embracing the new paradigm in pharma market access

Pharma needs to change its image from being drug producers to healthcare provider partners

UK flag

Life sciences industry wants more from new UK business strategy

BIA and ABPI welcome measures but tell government more can be done

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links